A heart attack and stroke are both medical emergencies caused by sudden disruption of blood flow, but they affect different ...

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

Ellie Roebuck has returned to Sarina Wiegman’s squad for the first time since 2023, having suffered a a left occipital ...

Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.

Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...

Argenica Therapeutics (ASX: AGN) has released new data from an independent pre-clinical study validating the efficacy and ...

Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment.

Imperative Care, Inc. announced late-breaking, real-world data from a multicenter review of 124 consecutive ischemic stroke ...

Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...

Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes ...